The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced a group of projects, designed to advance biopharmaceutical manufacturing and workforce development in the U.S.
The biopharma institute is based in Newark and will be part of a research center now under construction at the University of Delaware STAR campus. (See story link below). The institute has a staff of about two dozen.
The projects represent about $14 million of activity over 18 months and involve 24 unique organizations.
The projects were awarded in response to NIIMBL’s Quick Start Project (QSP) call as well as proposals initiated by NIIMBL state partners. One of the awards is for a Center of Excellence in Host-Cell Protein Analysis led by the University of Delaware.
“These projects are a significant milestone for the Institute. We appreciate the interest and enthusiasm with which our early members approached the proposal process and look forward to the transformative technologies and critical training solutions these projects promise to bring to the industry,” said Kelvin Lee, NIIMBL institute director.
Further details for each of these projects can be found at https://niimbl.force.com/s/current-projects
In addition, the NIIMBL Governing Committee authorized $18 million of funding for Project Call 1.0 projects. These projects further expand and deepen the work being done in support of biopharmaceutical manufacturing innovation.
All projects are subject to finalized contracts prior to launch.
NIIMBL is a public-private partnership with the goal of advancing innovation in biopharmaceutical manufacturing and workforce development. NIIMBL is part of Manufacturing USA, a network of 14 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research developments, accelerate new products to market, and train tomorrow’s workforce, a release stated.
NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce and leverages additional support from industry, academic institutions, non-profit organizations, as well state governments in Delaware, Maryland, North Carolina, and Massachusetts. (See earlier story).
Ground broken on $156 million biopharmaceutical institute on UD STAR Campus
